Company Filing History:
Years Active: 2025
Title: Keila Isaac-Olivé: Innovator in Radio-Imaging Technology
Introduction
Keila Isaac-Olivé is a prominent inventor based in Toluca, Mexico. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative delivery systems for radio-imaging applications. His work focuses on enhancing the effectiveness of imaging agents used in cancer detection and treatment.
Latest Patents
Keila holds a patent for "Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereof." This patent addresses the limitations of existing lipoprotein-based delivery systems in radio-imaging applications. The invention involves the synthesis of a novel hydrophobic radio-imaging tracer, which can be encapsulated into reconstituted HDL nanoparticles. These nanoparticles are designed to selectively target the Scavenger Receptor type B1 (SR-B1), which is overexpressed on cancer cells. This targeted approach allows for more effective in-vivo tumor imaging.
Career Highlights
Throughout his career, Keila has worked with esteemed institutions such as the University of North Texas and the Autonomous University of the State of Mexico. His research has focused on the synthesis and characterization of radio-imaging tracers, as well as their application in cancer diagnostics. His innovative work has the potential to significantly improve the accuracy of cancer detection.
Collaborations
Keila has collaborated with notable researchers in his field, including Andras G. Lacko and Laszlo Prokai. These collaborations have contributed to the advancement of knowledge in the area of nanotechnology and its applications in medicine.
Conclusion
Keila Isaac-Olivé is a trailblazer in the field of radio-imaging technology, with a focus on developing targeted delivery systems for cancer diagnostics. His innovative patent and collaborative efforts highlight his commitment to advancing medical imaging techniques. His work continues to pave the way for future innovations in the field.